• Thurs news: Sage R&D layoffs. Another Sanofi radiopharma deal. Novartis loses bid to block generic. Kezar lupus trial stopped. Why are so many pharmacies closing. See more on our front page

Both private equity firms who control a good portion of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)









This was posted months ago and is nothing new. It’s as generic as something can be written and appears to be more like a template with some numbers dropped in. It would be nice though to hear from the top about what’s going on.